Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Dermatologic 1

Conditions

Breast Neoplasms, Male 2Breast Neoplasms 2Melanoma 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × saponin QA-21V1 × Clear all
NCT00470574 2020-11-18

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed
7 enrolled 7 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00030823 2015-12-30

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Memorial Sloan Kettering Cancer Center

Phase NA Completed
14 enrolled 6 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00003224 2014-11-20

Vaccine Therapy in Treating Patients With Metastatic Melanoma

University of Virginia

Phase 1 Completed
22 enrolled 14 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡